Novo Nordisk A/S
NYSE:NVO

  • LAST PRICE
    132.0000
  • TODAY'S CHANGE (%)
    -4.9000 (-3.5793%)
  • Bid / Lots
    132.2000/ 1
  • Ask / Lots
    132.5000/ 6
  • Open / Previous Close
    133.6000 / 136.9000
  • Day Range
    131.8000
    135.1600
  • 52 Week Range
    86.9600
    148.1500
  • Volume
    3,514,820

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Diversified Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
NVO
Novo Nordisk A/S
464.0B
44.0x
+18.50%
CTLT
Catalent Inc
10.9B
-10.5x
---
PRGO
Perrigo Company PLC
3.8B
-33.6x
---
RPRX
Royalty Pharma PLC
16.9B
18.8x
+1.83%
JAZZ
Jazz Pharmaceuticals PLC
6.8B
19.2x
-3.53%
OGN
Organon & Co
5.4B
5.3x
-14.04%
As of 2024-09-17

Company Information

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Contact Information

Headquarters
Novo Alle 1BAGSVAERD, Denmark 2880
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Helge Lund
President, Chief Executive Officer
Lars Fruergaard Joergensen
Vice Chairman of the Board
Henrik Poulsen
Chief Financial Officer, Executive Vice President
Karsten Munk Knudsen
Executive Vice President - International Operations
Maziar Doustdar

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$464.0B
Revenue (TTM)
$38.5B
Shares Outstanding
3.4B
Dividend Yield
1.10%
Annual Dividend Rate
1.4462 USD
Ex-Dividend Date
08-16-24
Pay Date
08-26-24
Beta
0.43
EPS
$3.00
Book Value
$3.57
P/E Ratio
44.0x
Price/Sales (TTM)
12.1
Price/Cash Flow (TTM)
31.3x
Operating Margin
43.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.